PRESS RELEASE published on 11/10/2023 at 06:00, 1 year ago CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
PRESS RELEASE published on 11/08/2023 at 14:00, 1 year ago As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
PRESS RELEASE published on 11/02/2023 at 12:00, 1 year ago Bausch Health Announces Third-Quarter 2023 Results
PRESS RELEASE published on 11/01/2023 at 17:22, 1 year ago U.S. District Court Dismisses Norwich's Lawsuit Against the FDA
PRESS RELEASE published on 10/26/2023 at 14:00, 1 year ago Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
PRESS RELEASE published on 10/20/2023 at 23:20, 1 year 1 month ago FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
PRESS RELEASE published on 10/17/2023 at 14:00, 1 year 1 month ago New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
PRESS RELEASE published on 10/12/2023 at 14:00, 1 year 1 month ago Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
PRESS RELEASE published on 10/10/2023 at 14:00, 1 year 1 month ago Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
PRESS RELEASE published on 10/04/2023 at 14:00, 1 year 1 month ago Salix Pharmaceuticals Partners with Bellamy Young
Published on 11/25/2024 at 04:00, 1 hour 8 minutes ago Tanzania Safaris Unveils New Luxury Adventure Packages for 2025
Published on 11/22/2024 at 23:55, 2 days 5 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days 5 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days 6 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/24/2024 at 19:16, 9 hours 51 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/24/2024 at 19:07, 10 hours ago EQS-Adhoc: ABO Energy KGaA reduces forecast for the 2024 annual result to EUR 20 to 25 million and confirms market expectation for the 2025 financial year
Published on 11/22/2024 at 18:14, 2 days 10 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 2 days 11 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 06:58, 3 days 22 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 9 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 11 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days 11 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
